Colorectal cancer in ulcerative colitis: Survival in patients with and without colorectal cancer symptoms

Inflammatory Bowel Diseases

Volumn 2, Issue 1, 1996, Pages 6-10

  Giardiello, Francis M ^a,d   Gurbuz, Ahmet K ^c   Bayless, Theodore M ^a   Goodman, Steven N ^b   Yardley, John H ^b  

^a Division of Gastroenterology   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GULHANE SCHOOL OF MEDICINE   (Turkey)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Asymptomatic; Colorectal cancer; Prevention; Survival; Symptomatic; Ulcerative colitis

Indexed keywords

EID: 0002389161     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1002/ibd.3780020103     Document Type: Article

References (34)

1. Levin B. Gastrointestinal neoplasia in inflammatory bowel disease. In: Kirsner JB, Shorter RG, eds. Inflammatory bowel disease. 4th ed. Baltimore: Williams & Wilkins, 1995: 461-73.
2. Collins RH Jr, Feldman M, Fordtran JS. Colon cancer dysplasia, and surveillance in patients with ulcerative colitis: a critical review. N Engl J Med 1987;316:1654-8.
3. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer: a population based study. N Engl J Med 1990;323:1228-33.
4. Devroede GJ, Taylor WF, Sauer WG, Jackman RJ, Stickler GB. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 1971;285:17-21.
5. Devroede GJ, Taylor WF. On calculating cancer risk and survival of ulcerative colitis patients with the life table method. Gastroenterology 1976;71:505-9.
6. MacDougal IP. The cancer risk in ulcerative colitis. Lancet 1964;2:655-8.
7. Michener WM, Gage RP, Sauer WG, Strickler GB. The prognosis of chronic ulcerative colitis in children. N Engl J Med 1971;265:1075-9.
8. Prior P, Gyde SN, Macartney JC, Thompson H, Waterhouse JA, Allan RN. Cancer morbidity in ulcerative colitis. Gut 1982;23:490-7.
9. Maratka Z, Nedbal J, Kocianova J, Havelka J, Kudrmann J, Hendl J. Incidence of colorectal cancer in proctocolitis: a retrospective study of 959 cases over 40 years. Gut 1985;26: 43-9.
10. Gilat T, Fireman Z, Grossman A, et al. Colorectal cancer in patients with ulcerative colitis: a population study in central Israel. Gastroenterology 1988;94:870-7.
11. Gyde SN, Prior P, Allan RN, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referral from 3 centres. Gut 1988;29:206-17.
12. Katzka I, Brody RS, Morris E, Katz S. Assessment of colorectal cancer risk in patients with in ulcerative colitis; experience from a private practice. Gastroenterology 1983;85: 22-9.
13. Mir-Madjlessi SH, Farmer RG, Easley KA, Beck GJ. Colorectal and extracolonic malignancy in ulcerative colitis. Cancer 1986;58:1569-74.
14. Rosenstock E, Farmer RG, Petras R, Sivak MV Jr, Rankin GB, Sullivan BH. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 1985;89:1342-6.
15. Lennard-Jones JE, Morson BC, Ritchie JK, Williams CB. Cancer surveillance in ulcerative colitis: experience over 15 years. Lancet 1983;2:149-52.
16. Blackstone MO, Riddell RH, Rogers BHG, Levin B. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981;80:366-74.
17. Lennard-Jones JE, Morson BC, Path FRC, Ritchie JK, Shove DC, Williams CB. Cancer in colitis: assessment of the individual risk by clinical and histological criteria. Gastroenterology 1977;73:1280-9.
18. Nugent FW, Haggitt RC. Results of a longterm prospective surveillance program for dysplasia in ulcerative colitis. Gastroenterology 1984;86:1197.
19. Nugent FW, Haggitt RC, Giplin PA. Cancer surveillance in ulcerative colitis. Gastroenterology 1991;100:1241-8.
20. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983;14: 931-68.
21. Morson BC, Pang LSC. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 1967;8:423-34.
22. Lashner BA. Recommendations for colorectal cancer screening in ulcerative colitis: a review of research from a single university-based surveillance program. Am J Gastroenterol 1992;87:168-75.
23. Levin B, Lennard-Jones J, Riddell RH, Sachar D, Winawer SJ. Surveillance of patients with chronic ulcerative colitis. W.H.O. collaborating center for the prevention of colorectal cancer. Bull World Health Organ 1991;69:121-6.
24. Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990; 31:800-6.
25. Bozdech JM, Oakley JR, Farmer RG. Cancer surveillance in ulcerative colitis. Evidence for improved survival. Gastroenterology 1991;98:A199.
26. Axon ATR. Carcinogenesis in ulcerative colitis: is surveillance worthwhile? Can J Gastroenterol 1990;4:397-9.
27. Gyde S. Screening for colorectal cancer in ulcerative colitis: dubious benefits and high costs. Gut 1990;31:1089-92.
28. Lennard-Jones JE. Surveillance in ulcerative colitis: is it worthwhile? Does it save lives? Inflammatory Bowel Diseases 1995;1:76-9.
29. Shanahan F. Discontent with dysplasia surveillance in ulcerative colitis. Inflammatory Bowel Diseases 1995;1:80-3.
30. Choi PM, Nugent FW, Schoetz DJ, Silverman ML, Haggitt RC. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993; 105:418-23.
31. American Joint Committee on Cancer, Beahrs OH, ed. Manual for staging of cancer. 3rd ed. Philadelphia: Lippincott, 1988.
32. Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol 1932;35:323-32.
33. Cox DR. Regression models and life tables. J R Stat Soc B 1972;34:187-220.
34. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.